Ultragenyx Pharmaceutical Inc. (FRA:UP0)

Germany · Delayed Price · Currency is EUR

20.20

0.00 (0.00%)

At close: Jan 30, 2026

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America Revenue	361.23M	340.46M
Latin America Revenue	149.78M	130.71M
Europe Revenue	103.38M	80.12M
Asia-Pacific Revenue	16.21M	8.93M
Revenue (Total)	630.60M	560.23M

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Crysvita Revenue	159.23M	134.71M
Dojolvi Revenue	95.59M	88.19M
Evkeeza Revenue	52.70M	32.16M
Mepsevii Revenue	31.67M	30.35M
Total Product Revenue	339.19M	285.42M
Crysvita Royalty Revenue	291.41M	274.82M
Revenue (Other)	-52.70M	-32.16M
Revenue (Total)	630.60M	560.23M

Updated Sep 30, 2025. Data Source: Fiscal.ai.